Advertisement

Journal of Assisted Reproduction and Genetics

, Volume 28, Issue 2, pp 167–172 | Cite as

Non-invasive prenatal detection of achondroplasia using circulating fetal DNA in maternal plasma

  • Ji Hyae Lim
  • Mee Jin Kim
  • Shin Young Kim
  • Hye Ok Kim
  • Mee Jin Song
  • Min Hyoung Kim
  • So Yeon Park
  • Jae Hyug Yang
  • Hyun Mee Ryu
Technical Innovations

Abstract

Purpose

To perform a reliable non-invasive detection of the fetal achondroplasia using maternal plasma.

Methods

We developed a quantitative fluorescent-polymerase chain reaction (QF-PCR) method suitable for detection of the FGFR3 mutation (G1138A) causing achondroplasia. This method was applied in a non-invasive detection of the fetal achondroplasia using circulating fetal-DNA (cf-DNA) in maternal plasma. Maternal plasmas were obtained at 27 weeks of gestational age from women carrying an achondroplasia fetus or a normal fetus.

Results

Two percent or less achondroplasia DNA was reliably detected by QF-PCR. In a woman carrying a normal fetus, analysis of cf-DNA showed only one peak of the wild-type G allele. In a woman expected an achondroplasia fetus, analysis of cf-DNA showed the two peaks of wild-type G allele and mutant-type A allele and accurately detected the fetal achondroplasia.

Conclusions

The non-invasive method using maternal plasma and QF-PCR may be useful for diagnosis of the fetal achondroplasia.

Keywords

Achondroplasia Non-invasive prenatal diagnosis Maternal plasma QF-PCR 

Notes

Acknowledgements

The study was supported by a research grant of the Life Insurance Philanthropy Foundation.

References

  1. 1.
    Shiang R, Thompson LM, Zhu YZ, Church DM, Fielder TJ, Bocian M, et al. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell. 1994;78:335–42.PubMedCrossRefGoogle Scholar
  2. 2.
    Bellus GA, Hefferon TW, Ortiz de Luna RI, Hecht JT, Horton WA, Machado M, et al. Achondroplasia is defined by recurrent G380R mutations of FGFR3. Am J Hum Genet. 1995;56:368–73.PubMedGoogle Scholar
  3. 3.
    Rousseau F, Bonaventure J, Legeai-Mallet L, Pelet A, Rozet JM, Maroteaux P, et al. Mutations of the fibroblast growth factor receptor-3 gene in achondroplasia. Horm Res. 1996;45:108–10.PubMedCrossRefGoogle Scholar
  4. 4.
    Trujillo-Tiebas MJ, Fenollar-Cortés M, Lorda-Sánchez I, Díaz-Recasens J, Carrillo Redondo A, Ramos-Corrales C, et al. Prenatal diagnosis of skeletal dysplasia due to FGFR3 gene mutations: a 9-year experience: prenatal diagnosis in FGFR3 gene. J Assist Reprod Genet. 2009;26:455–60.PubMedCrossRefGoogle Scholar
  5. 5.
    Saito H, Sekizawa A, Morimoto T, Suzuki M, Yanaihara T. Prenatal DNA diagnosis of a single-gene disorder from maternal plasma. Lancet. 2000;356:1170.PubMedCrossRefGoogle Scholar
  6. 6.
    Li Y, Holzgreve W, Page-Christiaens GC, Gille JJ, Hahn S. Improved prenatal detection of a fetal point mutation for achondroplasia by the use of size-fractionated circulatory DNA in maternal plasma-case report. Prenat Diagn. 2004;24:896–8.PubMedCrossRefGoogle Scholar
  7. 7.
    Li Y, Page-Christiaens GC, Gille JJ, Holzgreve W, Hahn S. Non-invasive prenatal detection of achondroplasia in size-fractionated cell-free DNA by MALDI-TOF MS assay. Prenat Diagn. 2007;27:11–7.PubMedCrossRefGoogle Scholar
  8. 8.
    Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, et al. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997;350:485–7.PubMedCrossRefGoogle Scholar
  9. 9.
    Chiu RW, Lau TK, Leung TN, Chow KC, Chui DH, Lo YM. Prenatal exclusion of beta thalassaemia major by examination of maternal plasma. Lancet. 2002;360:998–1000.PubMedCrossRefGoogle Scholar
  10. 10.
    Chan KC, Zhang J, Hui AB, Wong N, Lau TK, Leung TN, et al. Size distributions of maternal and fetal DNA in maternal plasma. Clin Chem. 2004;50:88–92.PubMedCrossRefGoogle Scholar
  11. 11.
    Rijnders RJ, Van Der Luijt RB, Peters ED, Goeree JK, Van Der Schoot CE, Ploos Van Amstel JK, et al. Earliest gestational age for fetal sexing in cell-free maternal plasma. Prenat Diagn. 2003;23:1042–4.PubMedCrossRefGoogle Scholar
  12. 12.
    Clausen FB, Krog GR, Rieneck K, Nielsen LK, Lundquist R, Finning K, et al. Reliable test for prenatal prediction of fetal RhD type using plasma from RhD negative women. Prenat Diagn. 2005;25:1040–4.PubMedCrossRefGoogle Scholar
  13. 13.
    Legler TJ, Liu Z, Mavrou A, Finning K, Hromadnikova I, Galbiati S, et al. Workshop report on the extraction of foetal DNA from maternal plasma. Prenat Diagn. 2007;27:824–9.PubMedCrossRefGoogle Scholar
  14. 14.
    Cirigliano V, Ejarque M, Cañadas MP, Lloveras E, Plaja A, Perez MM, et al. Clinical application of multiplex quantitative fluorescent polymerase chain reaction (QF-PCR) for the rapid prenatal detection of common chromosome aneuploidies. Mol Hum Reprod. 2001;7:1001–6.PubMedCrossRefGoogle Scholar
  15. 15.
    Pertl B, Kopp S, Kroisel PM, Tului L, Brambati B, Adinolfi M. Rapid detection of chromosome aneuploidies by quantitative fluorescence PCR: first application on 247 chorionic villus samples. J Med Genet. 1999;36:300–3.PubMedGoogle Scholar
  16. 16.
    Schmidt W, Jenderny J, Hecher K, Hackelöer BJ, Kerber S, Kochhan L, et al. Detection of aneuploidy in chromosomes X, Y, 13, 18 and 21 by QF-PCR in 662 selected pregnancies at risk. Mol Hum Reprod. 2000;6:855–60.PubMedCrossRefGoogle Scholar
  17. 17.
    González-González C, Garcia-Hoyos M, Trujillo-Tiebas MJ, Lorda-Sanchez I, de Alba MR, Infantes F, et al. Application of fetal DNA detection in maternal plasma: a prenatal diagnosis unit experience. J Histochem Cytochem. 2005;53:307–14.PubMedCrossRefGoogle Scholar
  18. 18.
    González-González MC, Garcia-Hoyos M, Trujillo-Tiebas MJ, Bustamante Aragonés A, Rodriguez de Alba M, Diego Alvarez D, et al. Improvement in strategies for the non-invasive prenatal diagnosis of Huntington disease. J Assist Reprod Genet. 2008;25:477–81.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Ji Hyae Lim
    • 1
  • Mee Jin Kim
    • 1
  • Shin Young Kim
    • 1
  • Hye Ok Kim
    • 2
  • Mee Jin Song
    • 3
  • Min Hyoung Kim
    • 2
  • So Yeon Park
    • 1
  • Jae Hyug Yang
    • 2
  • Hyun Mee Ryu
    • 1
    • 2
  1. 1.Laboratory of Medical Genetics, Medical Research InstituteCheil General Hospital and Women’s Healthcare CenterSeoulSouth Korea
  2. 2.Department of Obstetrics and Gynecology, Cheil General Hospital & Women’s Healthcare CenterKwanDong University School of MedicineJung-guSouth Korea
  3. 3.Department of Radiology, Cheil General Hospital and Women’s Healthcare CenterKwanDong University College of MedicineSeoulSouth Korea

Personalised recommendations